Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

CDTCDT Equity Inc.

Nasdaq · CIK 0001896212
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts334

Identity from submissions API

NameCDT Equity Inc.
CIK0001896212
TickersCDT, CDTTW
ExchangesNasdaq, Nasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN873272543
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(646) 491 9132
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • CONDUIT PHARMACEUTICALS INC. (2023-03-01T05:00:00.000Z → 2025-08-07T04:00:00.000Z)
  • Murphy Canyon Acquisition Corp. (2021-12-09T05:00:00.000Z → 2023-09-21T04:00:00.000Z)
Business address
4851 TAMIAMI TRAIL NORTH
SUITE 200
NAPLES
FL
34103
FL
Mailing address
4851 TAMIAMI TRAIL NORTH
SUITE 200
NAPLES
FL
34103
FL

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

375 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-17 424B3 424B3 0001493152-26-052727 333-298808 261564183 33 827466
2026-11-16 10-Q 10-Q 0001493152-26-052618 001-41245 261563038 34 7995405 1 1
2026-11-16 424B3 424B3 0001493152-26-052570 333-298808 261562832 33 59812
2026-11-16 8-K 8-K 5.07 0001493152-26-052414 001-41245 261561410 34 261250 1 1
2026-11-09 424B3 424B3 0001493152-26-050633 333-298808 261533911 33 70188
2026-11-09 8-K 8-K 8.01 0001493152-26-050631 001-41245 261533872 34 255304 1 1
2026-11-06 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001753926-26-002067 005-93313 261529652 34 29580
2026-11-04 424B3 424B3 0001493152-26-049891 333-298808 261520317 33 95616
2026-11-04 8-K 8-K 3.03,5.03,9.01 0001493152-26-049889 001-41245 261520304 34 284949 1 1
2026-11-03 424B3 424B3 0001493152-26-049799 333-298808 261517656 33 116603
2026-10-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001753926-26-002012 005-93313 261491838 34 28371
2026-10-27 DEF 14A DEF 14A 0001493152-26-048693 001-41245 261491284 34 1479744
2026-10-27 4 xslF345X06/ownership.xml 0001753926-26-002011 11297
2026-10-27 4/A xslF345X06/ownership.xml 0001753926-26-002009 19687
2026-10-27 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001753926-26-002007 005-93313 261490912 34 21220
2026-10-27 3 xslF345X06/ownership.xml 0001753926-26-002005 4137
2026-10-27 8-K 8-K 1.01,3.02,7.01,9.01 0001493152-26-048638 001-41245 261487411 34 329365 1 1
2026-10-16 PRE 14A PRE 14A 0001493152-26-047422 001-41245 261466734 34 1478689
2026-10-13 424B3 424B3 0001493152-26-046739 333-298808 261454726 33 385803
2026-10-13 8-K 8-K 1.01,2.03,3.02,9.01 0001493152-26-046738 001-41245 261454693 34 635194 1 1
2026-10-08 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001753926-26-001917 005-93313 261449973 34 16256
2026-10-07 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001753926-26-001911 005-93313 261447094 34 28432
2026-10-07 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001753926-26-001910 005-93313 261447083 34 14151
2026-10-07 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001753926-26-001909 005-93313 261447069 34 8755
2026-10-02 424B3 424B3 0001493152-26-045443 333-298808 261433540 33 94322
2026-09-25 8-K 8-K 3.03,5.03,7.01,9.01 0001493152-26-044248 001-41245 261406312 34 306852 1 1
2026-09-18 424B3 424B3 0001493152-26-043404 333-298808 261391768 33 341819
2026-09-18 8-K 8-K 1.01,2.03,3.02,9.01 0001493152-26-043398 001-41245 261391743 34 586653 1 1
2026-09-18 424B3 424B3 0001493152-26-043361 333-298808 261391265 33 3626725
2026-09-17 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-003001 333-298808 261388336 33 1959
2026-09-09 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001753926-26-001737 005-93313 261369177 34 7740
2026-09-08 S-1 S-1 0001493152-26-041808 333-298808 261365998 33 17271889 1 1
2026-09-04 8-K 8-K 1.01,2.03,3.02,9.01 0001493152-26-041533 001-41245 261362131 34 640047 1 1
2026-09-02 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001753926-26-001700 005-93313 261356240 34 18832
2026-09-02 4 xslF345X06/ownership.xml 0001753926-26-001698 16795
2026-09-02 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001753926-26-001696 005-93313 261356225 34 16257
2026-09-01 8-K 8-K 8.01 0001493152-26-041016 001-41245 261351062 34 257249 1 1
2026-09-01 8-K 8-K 5.02,5.07,9.01 0001493152-26-040929 001-41245 261348551 34 414162 1 1
2026-08-21 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001753926-26-001589 005-93313 261305881 34 16137
2026-08-21 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001753926-26-001588 005-93313 261305860 34 23507
2026-08-21 8-K/A 8-K/A 9.01 0001493152-26-039588 001-41245 261302185 34 929870 1 1
2026-08-21 8-K/A 8-K/A 2.01,9.01 0001493152-26-039587 001-41245 261302178 34 634438 1 1
2026-08-12 10-Q 10-Q 0001493152-26-037458 001-41245 261268916 34 7118943 1 1
2026-08-12 DEFA14A DEFA14A 0001493152-26-037361 001-41245 261267660 34 1391255
2026-08-11 ARS ARS 0001493152-26-037000 001-41245 261260802 34 1780359
2026-08-11 DEF 14A DEF 14A 0001493152-26-036998 001-41245 261260787 34 3623681 1 1
2026-08-06 8-K 8-K 1.01,2.03,3.02,9.01 0001493152-26-036361 001-41245 261249685 34 527614 1 1
2026-08-03 8-K/A 8-K/A 2.01,9.01 0001493152-26-035831 001-41245 261233057 34 264528 1 1
2026-07-31 PRE 14A PRE 14A 0001493152-26-035687 001-41245 261229610 34 3619065 1 1
2026-07-31 8-K 8-K 1.01,3.02,9.01 0001493152-26-035682 001-41245 261229592 34 634847 1 1
2026-07-29 8-K 8-K 3.02 0001493152-26-035202 001-41245 261218108 34 249418 1 1
2026-07-16 8-K 8-K 3.03,5.03,7.01,9.01 0001493152-26-033455 001-41245 261178724 34 302747 1 1
2026-07-15 10-Q 10-Q 0001493152-26-033380 001-41245 261177864 34 6867814 1 1
2026-07-07 8-K 8-K 1.01,2.03,9.01 0001493152-26-032375 001-41245 261160162 34 702122 1 1
2026-06-29 8-K 8-K 4.01,9.01 0001493152-26-031093 001-41245 261136126 34 268226 1 1
2026-06-23 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001753926-26-001042 005-93313 261112562 34 24666
2026-06-23 4 xslF345X06/ownership.xml 0001753926-26-001040 16486
2026-06-16 8-K 8-K 1.01,2.03,3.02,8.01,9.01 0001493152-26-028909 001-41245 261095583 34 1424768 1 1
2026-06-05 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001753926-26-000992 005-93313 261070849 34 54945
2026-05-28 8-K 8-K 3.01,7.01,9.01 0001493152-26-025629 001-41245 261036710 34 273828 1 1
2026-05-20 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001213900-26-059720 005-93313 261005493 34 17727
2026-05-15 NT 10-Q NT 10-Q 0001493152-26-023832 001-41245 26988417 34 38384
2026-05-15 8-K 8-K 1.01,9.01 0001493152-26-023707 001-41245 26986704 34 359512 1 1
2026-05-14 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001753926-26-000869 005-93313 26976046 34 12977
2026-05-14 4 xslF345X06/ownership.xml 0001753926-26-000867 12801
2026-05-01 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001441 333-295226 26934439 33 1958
2026-05-01 424B3 424B3 0001493152-26-020920 333-295226 26933765 33 237298
2026-04-30 3 3 0001493152-26-020788 30158
2026-04-30 CORRESP filename1.htm 0001493152-26-019768 16680
2026-04-29 UPLOAD filename1.pdf 0000000000-26-004389 333-295226 147922
2026-04-27 8-K 8-K 5.02 0001493152-26-019133 001-41245 26900993 34 258259 1 1
2026-04-22 S-3 S-3 0001493152-26-018405 333-295226 26881143 33 612282 1 1
2026-04-15 10-K 10-K 0001493152-26-016858 001-41245 26864799 34 12269844 1 1
2026-04-02 424B5 424B5 0001493152-26-014923 333-282802 26833734 33 41637
2026-04-01 NT 10-K NT 10-K 0001493152-26-014626 001-41245 26828022 34 37359
2026-03-30 4 xslF345X06/ownership.xml 0001753926-26-000583 17963
2026-03-30 3 xslF345X06/ownership.xml 0001753926-26-000582 11536
2026-03-30 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0001753926-26-000581 005-93313 26816487 34 33098
2026-03-25 8-K 8-K 3.03,5.03,7.01,9.01 0001493152-26-012538 001-41245 26788445 34 303938 1 1
2026-03-18 8-K 8-K 5.07 0001493152-26-011270 001-41245 26770073 34 275641 1 1
2026-03-09 8-K 8-K 1.01,2.03,3.02,9.01 0001493152-26-009367 001-41245 26734909 34 1626091 1 1
2026-03-06 DEF 14A DEF 14A 0001493152-26-009143 001-41245 26731100 34 3003141
2026-02-24 8-K 8-K 1.01,3.02,9.01 0001493152-26-007906 001-41245 26672904 34 685978 1 1
2026-02-24 PRE 14A PRE 14A 0001493152-26-007899 001-41245 26672607 34 2950468
2026-02-23 4 4 0001493152-26-007794 8092
2026-02-18 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001753926-26-000333 005-93313 26650739 34 41626
2026-02-10 424B3 424B3 0001493152-26-005969 333-293062 26616287 33 240852
2026-02-09 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000486 333-293062 26613328 33 1958
2026-02-06 CORRESP filename1.htm 0001493152-26-005465 22641
2026-02-06 UPLOAD filename1.pdf 0000000000-26-001264 333-293062 40273
2026-01-30 S-8 S-8 0001493152-26-004346 333-293070 26580733 33 340000 1 1
2026-01-30 S-3 S-3 0001493152-26-004285 333-293062 26579885 33 634101 1 1
2026-01-22 8-K 8-K 1.01,3.02,9.01 0001493152-26-003244 001-41245 26551731 34 986284 1 1
2026-01-02 8-K 8-K 1.01,3.02,7.01,9.01 0001493152-26-000143 001-41245 26502801 34 452533 1 1
2025-12-22 4 4 0001493152-25-028761 13375
2025-12-22 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001493152-25-028760 005-93313 251592447 34 17255
2025-12-12 S-8 POS S-8 POS 0001493152-25-027522 333-289496 251568923 33 414486
2025-12-12 8-K 8-K 1.01,3.02,9.01 0001493152-25-027489 001-41245 251568300 34 510634 1 1
2025-11-13 10-Q 10-Q 0001493152-25-022373 001-41245 251479326 34 7552056 1 1
2025-10-09 8-K 8-K 3.03,5.03,7.01,9.01 0001493152-25-017533 001-41245 251383648 34 302565 1 1
2025-09-22 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001493152-25-014521 005-93313 251331131 34 16616
2025-09-22 4 xslF345X05/ownership.xml 0001493152-25-014477 8817
2025-09-19 4 xslF345X05/ownership.xml 0001493152-25-014283 5170
2025-08-26 4 4 0001641172-25-025542 7587
2025-08-26 4 4 0001641172-25-025539 10017
2025-08-26 4 4 0001641172-25-025538 7609
2025-08-18 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002066774-25-000003 005-93313 251228448 34 7263
2025-08-14 10-Q 10-Q 0001641172-25-024140 001-41245 251220661 34 8085323 1 1
2025-08-14 10-Q/A 10-Q/A 0001641172-25-024123 001-41245 251220531 34 6807349 1 1
2025-08-14 8-K 8-K 4.02 0001641172-25-023840 001-41245 251216835 34 262708 1 1
2025-08-12 424B3 424B3 0001641172-25-023191 333-289125 251206902 33 232625
2025-08-11 S-8 S-8 0001641172-25-023010 333-289496 251202983 33 339542 1 1
2025-08-08 8-K 8-K 5.02,5.03,5.07,7.01,9.01 0001641172-25-022760 001-41245 251198506 34 730823 1 1
2025-08-07 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002523 333-289125 251196048 33 1880
2025-08-05 UPLOAD filename1.pdf 0000000000-25-008236 333-289125 40332
2025-08-05 CORRESP filename1.htm 0001641172-25-022197 15535
2025-07-31 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001641172-25-021793 005-93313 251173318 34 42371
2025-07-31 S-3 S-3 0001641172-25-021729 333-289125 251171660 33 691375 1 1
2025-07-08 DEF 14A DEF 14A 0001641172-25-018242 001-41245 251112754 34 2961477 1 1
2025-07-08 ARS ARS 0001641172-25-018246 001-41245 251111770 34 1787243
2025-06-13 4 xslF345X05/ownership.xml 0001641172-25-014963 10728
2025-06-09 8-K 8-K 1.01,3.02,7.01,9.01 0001641172-25-014322 001-41245 251034512 34 413137 1 1
2025-06-03 8-K 8-K 5.08 0001641172-25-013468 001-41245 251020071 34 256787 1 1
2025-05-16 8-K 8-K 3.03,5.03,7.01,9.01 0001641172-25-011183 001-41245 25957071 34 310209 1 1
2025-05-15 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001641172-25-010946 005-93313 25953563 34 13946
2025-05-15 10-Q 10-Q 0001641172-25-010405 001-41245 25947783 34 6486053 1 1
2025-05-07 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002066774-25-000002 005-93313 25923049 34 6995
2025-05-07 3 PRIMARY DOCUMENT 0002066774-25-000001 3959
2025-05-06 8-K 8-K 5.07 0001641172-25-008854 001-41245 25917751 34 266551 1 1
2025-04-30 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-001314 333-286684 25899093 33 1879
2025-04-28 CORRESP filename1.htm 0001641172-25-006420 21197
2025-04-28 UPLOAD filename1.pdf 0000000000-25-004451 333-286684 40216
2025-04-25 DEF 14A formdef14a.htm 0001641172-25-006259 001-41245 25875051 34 1252162
2025-04-25 8-K form8-k.htm 4.01,9.01 0001641172-25-006224 001-41245 25874600 34 276540 1 1
2025-04-22 S-3 forms-3.htm 0001641172-25-005732 333-286684 25858623 33 543150
2025-04-17 4 xslF345X05/ownership.xml 0001641172-25-005221 5102
2025-04-16 PRE 14A formpre14a.htm 0001641172-25-005096 001-41245 25843565 34 1348718
2025-04-16 8-K form8-k.htm 5.02,7.01,9.01 0001641172-25-005036 001-41245 25842755 34 386974 1 1
2025-04-10 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-033481 005-93313 25826353 34 9519
2025-04-04 8-K form8-k.htm 1.01,3.02 0001641172-25-002774 001-41245 25815167 34 263796 1 1
2025-04-02 8-K/A form8-ka.htm 8.01 0001641172-25-002400 001-41245 25805319 34 265347 1 1
2025-04-01 4 xslF345X05/ownership.xml 0001641172-25-002240 7308
2025-04-01 4 xslF345X05/ownership.xml 0001641172-25-002238 4876
2025-04-01 4 xslF345X05/ownership.xml 0001641172-25-002236 4898
2025-04-01 4 xslF345X05/ownership.xml 0001641172-25-002234 4941
2025-04-01 8-K form8-k.htm 8.01 0001641172-25-002147 001-41245 25800975 34 261545 1 1
2025-03-28 10-K form10-k.htm 0001641172-25-001246 001-41245 25787301 34 11517043 1 1
2025-03-10 424B5 form424b5.htm 0001493152-25-009708 333-282802 25724191 33 18889
2025-03-06 8-K form8-k.htm 8.01 0001493152-25-009330 001-41245 25713704 34 269486 1 1
2025-02-20 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001213900-25-015704 005-93313 25645966 34 12741
2025-02-19 8-K form8-k.htm 1.02,3.01,8.01 0001493152-25-007573 001-41245 25640197 34 267100 1 1
2025-02-19 424B5 form424b5.htm 0001493152-25-007520 333-282802 25637598 33 27804
2025-02-14 424B3 form424b3.htm 0001493152-25-006960 333-284714 25630824 33 354920
2025-02-12 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000429 333-284714 25616934 33 1886
2025-02-11 CORRESP filename1.htm 0001493152-25-005917 23749
2025-02-11 UPLOAD filename1.pdf 0000000000-25-001476 333-284714 40268
2025-02-11 8-K form8-k.htm 8.01 0001493152-25-005796 001-41245 25607711 34 267435 1 1
2025-02-10 424B5 form424b5.htm 0001493152-25-005647 333-282802 25606129 33 46573
2025-02-06 S-8 forms-8.htm 0001493152-25-005249 333-284741 25598446 33 498437
2025-02-06 424B5 form424b5.htm 0001493152-25-005099 333-282802 25595623 33 24887
2025-02-05 S-3 forms-3.htm 0001493152-25-005052 333-284714 25594628 33 679965
2025-01-23 8-K form8-k.htm 3.03,5.03,7.01,9.01 0001493152-25-003316 001-41245 25547682 34 321954 1 1
2025-01-21 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001213900-25-005052 005-93313 25543161 34 18654
2025-01-15 424B5 form424b5.htm 0001493152-25-002388 333-282802 25533258 33 17901
2025-01-14 8-K form8-k.htm 5.07 0001493152-25-002176 001-41245 25529865 34 274052 1 1
2024-12-20 4 xslF345X05/ownership.xml 0001493152-24-051098 5806
2024-12-20 4 xslF345X05/ownership.xml 0001493152-24-051097 5849
2024-12-20 4 xslF345X05/ownership.xml 0001493152-24-051099 5849
2024-12-20 4 xslF345X05/ownership.xml 0001493152-24-051096 5680
2024-12-20 3 xslF345X02/ownership.xml 0001493152-24-051095 3645
2024-12-20 8-K form8-k.htm 3.01,5.07 0001493152-24-051089 001-41245 241568750 34 284673 1 1
2024-12-17 8-K form8-k.htm 1.01,3.02,7.01,9.01 0001493152-24-050443 001-41245 241556708 34 769767 1 1
2024-12-16 424B3 form424b3.htm 0001493152-24-050261 333-275056 241552639 33 15115833 1 1
2024-12-09 424B3 form424b3.htm 0001493152-24-049174 333-283449 241533732 33 307308
2024-12-06 DEF 14A formdef14a.htm 0001493152-24-049097 001-41245 241533932 34 2002102
2024-12-06 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-12-06 16:30:00 9999999995-24-003695 333-283449 241533662 33 1887
2024-12-04 CORRESP filename1.htm 0001493152-24-048645 39501
2024-12-02 UPLOAD filename1.pdf 0000000000-24-013248 333-283449 40214
2024-11-26 PRE 14A formpre14a.htm 0001493152-24-047823 001-41245 241505434 34 2373485
2024-11-25 S-3 forms-3.htm 0001493152-24-047639 333-283449 241496986 33 537573
2024-11-25 8-K form8-k.htm 1.01,2.03,3.02,9.01 0001493152-24-047631 001-41245 241496738 34 438871 1 1
2024-11-20 4 xslF345X05/ownership.xml 0001493152-24-046993 7281
2024-11-20 4 xslF345X05/ownership.xml 0001493152-24-046994 5670
2024-11-20 4 xslF345X05/ownership.xml 0001493152-24-046992 4867
2024-11-20 4 xslF345X05/ownership.xml 0001493152-24-046990 5643
2024-11-20 4 xslF345X05/ownership.xml 0001493152-24-046991 6519
2024-11-19 8-K form8-k.htm 5.02,5.03,9.01 0001493152-24-046849 001-41245 241477064 34 519649 1 1
2024-11-14 10-Q form10-q.htm 0001493152-24-046088 001-41245 241464521 34 7611343 1 1
2024-11-14 10-Q/A form10-qa.htm 0001493152-24-046080 001-41245 241464468 34 7577048 1 1
2024-11-14 10-Q/A form10-qa.htm 0001493152-24-046074 001-41245 241464436 34 5819084 1 1
2024-11-14 8-K form8-k.htm 4.02 0001493152-24-046068 001-41245 241464390 34 272135 1 1
2024-11-06 SC 13G/A SC 13G/A 0001193125-24-251501 005-93313 241429051 34 38897
2024-11-04 424B5 form424b5.htm 0001493152-24-043555 333-282802 241424786 33 1207077
2024-11-04 424B3 form424b3.htm 0001493152-24-043553 333-282802 241424779 33 1047712
2024-11-01 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-11-01 16:30:00 9999999995-24-003346 333-282802 241420513 33 1867
2024-11-01 DEFA14A formdefa14a.htm 0001493152-24-043366 001-41245 241419968 34 22804
2024-11-01 8-K form8-k.htm 1.01,1.02,2.03,3.02,9.01 0001493152-24-043330 001-41245 241419270 34 708162 1 1
2024-10-31 CORRESP filename1.htm 0001493152-24-043152 65342
2024-10-29 UPLOAD filename1.pdf 0000000000-24-012050 333-282802 40229
2024-10-28 ARS ars.pdf 0001493152-24-042721 001-41245 241401888 34 1509378
2024-10-28 DEFA14A formdefa14a.htm 0001493152-24-042719 001-41245 241401861 34 2110602
2024-10-28 DEF 14A formdef14a.htm 0001493152-24-042718 001-41245 241401850 34 7845493
2024-10-24 S-3 forms-3.htm 0001493152-24-042298 333-282802 241390521 33 1819718
2024-10-18 SC 13G/A AMENDMENT NO. 3 TO SCHEDULE 13G 0001213900-24-088956 005-93313 241380926 34 132877
2024-10-16 PRE 14A formpre14a.htm 0001493152-24-041325 001-41245 241375348 34 7974236
2024-10-15 8-K form8-k.htm 1.01,2.03,9.01 0001493152-24-041154 001-41245 241372525 34 377365 1 1
2024-10-11 SC 13G SC 13G 0001104659-24-107836 005-93313 241366252 34 55659
2024-10-07 4 xslF345X05/ownership.xml 0001213900-24-086022 13990
2024-10-07 SC 13G/A AMENDMENT NO. 2 TO SCHEDULE 13G 0001213900-24-086021 005-93313 241358932 34 132472
2024-10-02 4 xslF345X05/ownership.xml 0001213900-24-084702 13992
2024-09-19 4 xslF345X05/ownership.xml 0001493152-24-037150 33652
2024-09-19 SC 13D/A formsc13da.htm 0001493152-24-037144 005-93313 241311080 34 10643748
2024-09-17 424B3 form424b3.htm 0001493152-24-036870 333-281933 241304971 33 2982178
2024-09-16 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-09-16 16:30:00 9999999995-24-002854 333-281933 241302419 33 1867
2024-09-16 CORRESP filename1.htm 0001493152-24-036269 13465
2024-09-13 S-1/A forms-1a.htm 0001493152-24-036199 333-281933 241297749 33 865645
2024-09-06 8-K form8-k.htm 5.08 0001493152-24-035334 001-41245 241285113 34 268147 1 1
2024-09-04 S-1 forms-1.htm 0001493152-24-034991 333-281933 241278133 33 15297490 1 1
2024-08-19 424B3 form424b3.htm 0001493152-24-033121 333-275056 241221427 33 841400
2024-08-16 8-K form8-k.htm 3.01,8.01 0001493152-24-032854 001-41245 241217393 34 270280 1 1
2024-08-13 3 xslF345X02/ownership.xml 0001213900-24-068299 12390
2024-08-13 SC 13G/A AMENDMENT NO. 1 TO SCHEDULE 13G 0001213900-24-068294 005-93313 241202102 34 134024
2024-08-12 10-Q form10-q.htm 0001493152-24-031385 001-41245 241198073 34 7018159 1 1
2024-08-08 8-K form8-k.htm 1.01,3.02,9.01 0001493152-24-030681 001-41245 241186230 34 304045 1 1
2024-08-07 8-K form8-k.htm 1.01,2.03,3.02,9.01 0001493152-24-030568 001-41245 241184751 34 409876 1 1
2024-07-11 8-K/A form8-ka.htm 5.08 0001493152-24-026957 001-41245 241112215 34 267371 1 1
2024-07-01 8-K form8-k.htm 5.08 0001493152-24-025805 001-41245 241091076 34 262237 1 1
2024-06-11 4 xslF345X05/ownership.xml 0001493152-24-023518 4820
2024-06-11 4 xslF345X05/ownership.xml 0001493152-24-023516 4799
2024-05-31 8-K form8-k.htm 3.01 0001493152-24-022228 001-41245 241010660 34 262895 1 1
2024-05-16 424B3 form424b3.htm 0001493152-24-020260 333-275056 24956060 33 729864
2024-05-15 4 xslF345X05/ownership.xml 0001493152-24-019918 4610
2024-05-15 4 xslF345X05/ownership.xml 0001493152-24-019926 5711
2024-05-14 10-Q form10-q.htm 0001493152-24-019230 001-41245 24944244 34 5726065 1 1
2024-05-02 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001493152-24-017464,2024-05-02 9999999995-24-001346 333-275056 24910650 33 1879
2024-05-02 POS AM formposam.htm 0001493152-24-017464 333-275056 24904652 33 11191469 1 1
2024-04-24 4 xslF345X05/ownership.xml 0001493152-24-015812 7810
2024-04-24 4 xslF345X05/ownership.xml 0001493152-24-015813 10596
2024-04-24 4 xslF345X05/ownership.xml 0001493152-24-015814 7799
2024-04-16 10-K form10-k.htm 0001493152-24-014889 001-41245 24848820 34 11467119 1 1
2024-04-16 8-K form8-k.htm 4.02,9.01 0001493152-24-014883 001-41245 24848801 34 276936 1 1
2024-04-01 NT 10-K formnt10-k.htm 0001493152-24-012414 001-41245 24809849 34 36785
2024-02-12 SC 13G/A CONDUIT PHARMACEUTICALS INC. 0001326389-24-000080 005-93313 24618702 34 7452
2024-02-08 SC 13G/A FORM SC 13G/A 0001062993-24-002422 005-93313 24608072 34 53745
2024-02-02 SC 13G/A CDT 13G/A 0001393825-24-000031 005-93313 24591915 34 56459
2024-01-10 S-8 forms-8.htm 0001493152-24-001959 333-276461 24527062 33 158625
2023-12-18 424B3 form424b3.htm 0001493152-23-045267 333-275056 231493879 33 3323280
2023-12-15 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2023-12-15 16:30:00 9999999995-23-003652 333-275056 231492120 33 1867
2023-12-14 4 xslF345X05/ownership.xml 0001493152-23-044917 5620
2023-12-13 CORRESP filename1.htm 0001493152-23-044736 12200
2023-12-05 4 xslF345X05/ownership.xml 0001493152-23-043745 5545
2023-12-05 4 xslF345X05/ownership.xml 0001493152-23-043747 5577
2023-12-05 4 xslF345X05/ownership.xml 0001493152-23-043748 5634
2023-12-05 4 xslF345X05/ownership.xml 0001493152-23-043746 5620
2023-12-05 4 xslF345X05/ownership.xml 0001493152-23-043750 5564
2023-12-05 4 xslF345X05/ownership.xml 0001493152-23-043749 4786
2023-12-01 S-8 forms-8.htm 0001493152-23-043433 333-275860 231460271 33 193479
2023-12-01 CORRESP filename1.htm 0001493152-23-043432 29676
2023-12-01 S-1/A forms-1a.htm 0001493152-23-043429 333-275056 231460247 33 17683825 1 1
2023-11-21 10-Q/A form10-qa.htm 0001493152-23-042184 001-41245 231424231 34 6580580 1 1
2023-11-20 10-Q form10-q.htm 0001493152-23-042176 001-41245 231423748 34 6573837 1 1
2023-11-14 NT 10-Q formnt10-q.htm 0001493152-23-041189 001-41245 231407165 34 37824
2023-10-30 UPLOAD filename1.pdf 0000000000-23-011858 51224
2023-10-17 S-1 forms-1.htm 0001493152-23-037514 333-275056 231330140 33 14239589 1 1
2023-10-05 8-K/A form8-ka.htm 1.01,2.01,3.01,3.02,3.03,5.01,5.02,5.03,5.05,5.06,7.01,9.01 0001493152-23-036388 001-41245 231312215 34 1615707 1 1
2023-10-02 SC 13G SCHEDULE 13G 0001013762-23-000480 005-93313 231300108 34 115301
2023-09-29 SC 13G formsc13g.htm 0001493152-23-034862 005-93313 231296110 34 75550
2023-09-29 SC 13D/A formsc13da.htm 0001493152-23-034861 005-93313 231296111 34 92392
2023-09-29 SC 13D formsc13d.htm 0001493152-23-034860 005-93313 231296112 34 127307
2023-09-29 8-K form8-k.htm 1.01,2.01,3.01,3.02,3.03,5.01,5.02,5.03,5.05,5.06,7.01,9.01 0001493152-23-034700 001-41245 231291413 34 1623576 1 1
2023-09-26 4 xslF345X05/ownership.xml 0001493152-23-033793 8131
2023-09-26 3 xslF345X02/ownership.xml 0001493152-23-033788 2999
2023-09-26 3 xslF345X02/ownership.xml 0001493152-23-033787 2916
2023-09-26 3 xslF345X02/ownership.xml 0001493152-23-033784 8227
2023-09-26 3 xslF345X02/ownership.xml 0001493152-23-033782 9391
2023-09-26 3 xslF345X02/ownership.xml 0001493152-23-033779 4381
2023-09-26 3 xslF345X02/ownership.xml 0001493152-23-033780 2990
2023-09-26 4 xslF345X05/ownership.xml 0001493152-23-033776 15374
2023-09-22 25-NSE xslF25X02/primary_doc.xml 0001354457-23-000694 333-262036 231272138 34 3018
2023-09-22 CERT CDT_8-ACert.pdf 0001354457-23-000693 001-41245 231272137 34 253097
2023-09-22 8-A12B form8-a12b.htm 0001493152-23-033397 001-41245 231270363 34 29842
2023-09-21 8-K form8-k.htm 5.07,8.01,9.01 0001493152-23-033241 001-41245 231267302 34 367748 1 1
2023-09-13 424B3 form424b3.htm 0001493152-23-032451 333-271903 231252278 33 531047
2023-09-13 425 form425.htm 0001493152-23-032448 001-41245 231252270 34 522670
2023-09-13 8-K form8-k.htm 1.01,8.01,9.01 0001493152-23-032446 001-41245 231252264 34 850598 1 1
2023-09-07 425 form425.htm 0001493152-23-031985 001-41245 231242673 34 77944
2023-09-07 8-K form8-k.htm 8.01,9.01 0001493152-23-031984 001-41245 231242669 34 329688 1 1
2023-08-31 425 form425.htm 0001493152-23-031216 001-41245 231229584 34 84105
2023-08-31 8-K form8-k.htm 8.01,9.01 0001493152-23-031057 001-41245 231229266 34 336187 1 1
2023-08-23 425 form425.htm 0001493152-23-029965 001-41245 231198039 34 1164785
2023-08-23 8-K form8-k.htm 8.01,9.01 0001493152-23-029962 001-41245 231198013 34 1422820 1 1
2023-08-23 424B3 form424b3.htm 0001493152-23-029958 333-271903 231197976 33 2887358
2023-08-16 425 form425.htm 0001493152-23-029077 001-41245 231176554 34 79651
2023-08-16 8-K form8-k.htm 8.01,9.01 0001493152-23-029076 001-41245 231176549 34 331392 1 1
2023-08-14 10-Q form10-q.htm 0001493152-23-028647 001-41245 231171968 34 3917762 1 1
2023-08-11 SEC STAFF LETTER filename1.pdf 9999999997-23-003864 63576
2023-08-11 EFFECT xslEFFECTX01/primary_doc.xml S-4,,2023-08-11 16:30:00 9999999995-23-002356 333-271903 231165942 33 1716
2023-08-11 424B3 form424b3.htm 0001493152-23-027856 333-271903 231164816 33 16477242
2023-08-10 CORRESP filename1.htm 0001493152-23-027443 10265
2023-08-08 CORRESP filename1.htm 0001493152-23-027180 13634
2023-08-08 S-4/A forms-4a.htm 0001493152-23-027178 333-271903 231151766 33 38212877 1 1
2023-08-07 UPLOAD filename1.pdf 0000000000-23-008544 43567
2023-07-28 S-4/A forms-4a.htm 0001493152-23-025880 333-271903 231123270 33 36995402 1 1
2023-07-28 CORRESP filename1.htm 0001493152-23-025877 254741
2023-07-21 425 form425.htm 0001493152-23-025268 001-41245 231103284 34 14536049
2023-07-21 8-K form8-k.htm 7.01,9.01 0001493152-23-025267 001-41245 231103281 34 14780879 1 1
2023-07-20 UPLOAD filename1.pdf 0000000000-23-007758 53352
2023-07-11 S-4/A forms-4a.htm 0001493152-23-024231 333-271903 231082480 33 30821811 1 1
2023-07-11 CORRESP filename1.htm 0001493152-23-024232 89652
2023-05-31 UPLOAD filename1.pdf 0000000000-23-005724 77916
2023-05-30 SEC STAFF LETTER filename1.pdf 9999999997-23-003024 64855
2023-05-15 10-Q form10-q.htm 0001493152-23-017281 001-41245 23922060 34 3581625 1 1
2023-05-12 CORRESP filename1.htm 0001493152-23-016745 687262
2023-05-12 S-4 forms-4.htm 0001493152-23-016741 333-271903 23917065 33 17966599 1 1
2023-05-11 425 form425.htm 0001493152-23-016409 001-41245 23911586 34 72626
2023-05-11 8-K form8-k.htm 1.01,9.01 0001493152-23-016403 001-41245 23911552 34 322010 1 1
2023-04-14 8-K form8-k.htm 3.01 0001493152-23-012305 001-41245 23821337 34 272237 1 1
2023-03-28 10-K form10-k.htm 0001493152-23-009306 001-41245 23770454 34 4971998 1 1
2023-03-08 8-K form8-k.htm 1.01,2.03,9.01 0001493152-23-006939 001-41245 23714237 34 312139 1 1
2023-03-01 UPLOAD filename1.pdf 0000000000-23-002085 118099
2023-02-16 SC 13D formsc13d.htm 0001766806-23-000091 005-93313 23639501 34 53974
2023-02-14 SC 13G/A FORM SC 13G/A 0001062993-23-003252 005-93313 23625297 34 68269
2023-02-10 SC 13G MURF 13G 0001393825-23-000131 005-93313 23611193 34 61545
2023-02-10 SC 13G MURPHYCANYON_POLAR 0001326389-23-000558 005-93313 23610272 34 6613
2023-02-08 3 PRIMARY DOCUMENT 0001766806-23-000005 3653
2023-02-08 SC 13G/A MURFU13GAMEND 0001846718-23-000030 005-93313 23596635 34 7559
2023-02-03 8-K form8-k.htm 5.03,8.01,9.01 0001493152-23-003557 001-41245 23587229 34 299177 1 1
2023-02-01 8-K form8-k.htm 5.07,9.01 0001493152-23-003317 001-41245 23577686 34 294854 1 1
2023-02-01 DRS filename1.htm 0001493152-23-003311 377-06573 23577372 33 9754971
2023-01-30 425 form425.htm 0001493152-23-002975 001-41245 23568708 34 242463
2023-01-30 8-K form8-k.htm 1.01,9.01 0001493152-23-002970 001-41245 23568688 34 527748 1 1
2023-01-30 SC 13D/A formsc13d.htm 0001493152-23-002969 005-93313 23568678 34 139206
2023-01-03 DEF 14A formdef14a.htm 0001493152-23-000134 001-41245 23502631 34 1654641
2022-12-23 PRE 14A formpre14a.htm 0001493152-22-036427 001-41245 221484571 34 1173109
2022-11-25 UPLOAD filename1.pdf 0000000000-22-012761 39646
2022-11-23 CORRESP filename1.htm 0001493152-22-033607 15586
2022-11-21 UPLOAD filename1.pdf 0000000000-22-012607 45062
2022-11-14 425 form425.htm 0001493152-22-032113 001-41245 221386452 34 1371552
2022-11-14 8-K form8-k.htm 1.01,3.02,9.01 0001493152-22-032104 001-41245 221386363 34 1852836 1 1
2022-11-08 425 form425.htm 0001493152-22-030986 001-41245 221369733 34 10790010
2022-11-08 8-K form8-k.htm 7.01,9.01 0001493152-22-030981 001-41245 221369712 34 11043126 1 1
2022-11-07 10-Q form10-q.htm 0001493152-22-030830 001-41245 221365847 34 3020106 1 1
2022-08-11 10-Q form10-q.htm 0001493152-22-022098 001-41245 221156241 34 2942745 1 1
2022-05-18 10-Q form10-q.htm 0001493152-22-014244 001-41245 22936509 34 2969055 1 1
2022-05-16 NT 10-Q formnt10-q.htm 0001493152-22-013983 001-41245 22931195 34 31641
2022-03-29 10-K form10-k.htm 0001493152-22-008049 001-41245 22781742 34 3303261 1 1
2022-03-28 8-K form8-k.htm 8.01 0001493152-22-007819 001-41245 22773335 34 29032
2022-02-14 SC 13D formsc13d.htm 0001493152-22-004468 005-93313 22632937 34 137991
2022-02-14 8-K form8-k.htm 8.01,9.01 0001493152-22-004164 001-41245 22624293 34 167337
2022-02-11 3 xslF345X02/ownership.xml 0001493152-22-004025 2865
2022-02-11 3 xslF345X02/ownership.xml 0001493152-22-004024 8340
2022-02-11 3 xslF345X02/ownership.xml 0001493152-22-004026 2880
2022-02-11 3 xslF345X02/ownership.xml 0001493152-22-004028 2867
2022-02-11 3 xslF345X02/ownership.xml 0001493152-22-004031 2884
2022-02-11 3 xslF345X02/ownership.xml 0001493152-22-004029 8747
2022-02-11 3 xslF345X02/ownership.xml 0001493152-22-004030 2877
2022-02-11 SC 13G FORM SC 13G 0001062993-22-003762 005-93313 22620491 34 56336
2022-02-10 SC 13G FORM SC 13G 0001062993-22-003520 005-93313 22613790 34 45114
2022-02-08 8-K form8-k.htm 1.01,3.02,5.03,8.01,9.01 0001493152-22-003484 001-41245 22602196 34 1080148
2022-02-04 424B5 form424b5.htm 0001493152-22-003262 333-262036 22593921 33 2848663
2022-02-04 SC 13G murphy13ginitial.txt 0001846718-22-000076 005-93313 22591667 34 7396
2022-02-02 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2022-02-02 16:30:00 9999999995-22-000306 333-262036 22586343 33 1700
2022-02-01 CORRESP filename1.htm 0001493152-22-002860 9199
2022-02-01 CORRESP filename1.htm 0001493152-22-002858 8208
2022-01-28 S-1/A forms-1a.htm 0001493152-22-002595 333-262036 22570218 33 3896004
2022-01-26 RW WD formrwwd.htm 0001493152-22-002265 333-262036 22556550 NE 16834
2022-01-26 CORRESP filename1.htm 0001493152-22-002262 8455
2022-01-26 RW formrw.htm 0001493152-22-002218 333-262036 22555134 NE 13465
2022-01-25 CERT 8A_Cert_MURF.pdf 0001354457-22-000070 001-41245 22553300 34 216411
2022-01-24 8-A12B form8-a12b.htm 0001493152-22-002074 001-41245 22548292 34 29961
2022-01-21 CORRESP filename1.htm 0001493152-22-001954 12042
2022-01-21 CORRESP filename1.htm 0001493152-22-001951 9998
2022-01-06 S-1 forms-1.htm 0001493152-22-000566 333-262036 22515068 33 3891042
2021-12-20 UPLOAD filename1.pdf 0000000000-21-015145 40878
2021-12-09 DRS filename1.htm 0001493152-21-030970 377-05773 211482325 33 2491070

Latest XBRL company facts

One latest value per concept from companyfacts (334 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 1.90M 2026-11-16 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
dei EntityListingParValuePerShare Entity Listing, Par Value Per Share USD/shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
dei EntityPublicFloat Entity Public Float USD 55,200 2025-06-30 2025 FY 10-K 2026-04-15 0001493152-26-016858
ffd NetFeeAmt NetFeeAmt USD 1,835.66 2026-09-08 S-1 2026-09-08 0001493152-26-041808
ffd TtlFeeAmt TtlFeeAmt USD 1,835.66 2026-09-08 S-1 2026-09-08 0001493152-26-041808
ffd TtlOfferingAmt TtlOfferingAmt USD 13.29M 2026-09-08 S-1 2026-09-08 0001493152-26-041808
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-09-08 S-1 2026-09-08 0001493152-26-041808
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-09-08 S-1 2026-09-08 0001493152-26-041808
us-gaap AccountsNotesAndLoansReceivableNetCurrent Accounts and Financing Receivable, after Allowance for Credit Loss, Current USD 525,000 2024-09-30 2024 Q3 10-Q 2024-11-14 0001493152-24-046088
us-gaap AccountsPayableAndOtherAccruedLiabilitiesCurrent Accounts Payable and Other Accrued Liabilities, Current USD 16.42M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 4.51M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap AccountsPayableOtherCurrent Accounts Payable, Other, Current USD 146,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap AccountsPayableRelatedPartiesCurrent Accounts Payable, Related Parties, Current USD 3,875 2022-03-31 2022 Q1 10-Q 2022-05-18 0001493152-22-014244
us-gaap AccruedBonusesCurrent Accrued Bonuses, Current GBP 100.00M 2025-04-12 2025 Q1 10-Q/A 2025-08-14 0001641172-25-024123
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 111,724 2023-06-30 2023 Q2 10-Q 2023-08-14 0001493152-23-028647
us-gaap AccruedInsuranceCurrent Accrued Insurance, Current USD 1.07M 2023-09-30 2023 Q3 10-Q/A 2023-11-21 0001493152-23-042184
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 4.60M 2023-09-30 2023 Q3 10-Q/A 2023-11-21 0001493152-23-042184
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 9.60M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap AccruedLiabilitiesCurrentAndNoncurrent Accrued Liabilities USD 400,000 2024-12-31 2024 FY 10-K 2025-03-28 0001641172-25-001246
us-gaap AccruedPayrollTaxesCurrent Accrued Payroll Taxes, Current USD 14,000 2025-12-31 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 388,000 2025-12-31 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap AccruedSalesCommissionCurrent Accrued Sales Commission, Current USD 107,000 2024-12-31 2025 Q3 10-Q 2025-11-13 0001493152-25-022373
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 165,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 217.84M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap AdjustmentForAmortization Amortization USD 926,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap AdjustmentOfWarrantsGrantedForServices Adjustment of Warrants Granted for Services USD 2.71M 2024-01-01 2024-09-30 2025 Q3 10-Q 2025-11-13 0001493152-25-022373
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 600,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 145.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 400,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-16 0001493152-24-014889
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 143,000 2024-01-01 2024-09-30 2025 Q3 10-Q 2025-11-13 0001493152-25-022373
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 7,668 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap Assets Assets USD 158.73M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap AssetsCurrent Assets, Current USD 4.39M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap AssetsHeldInTrust Assets Held-in-trust USD 23.30M 2023-06-30 2023 Q2 10-Q 2023-08-14 0001493152-23-028647
us-gaap AssetsHeldInTrustNoncurrent Assets Held-in-trust, Noncurrent USD 23.34M 2023-06-30 2023 Q2 10-Q 2023-08-14 0001493152-23-028647
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 78,000 2024-09-30 2024 Q3 10-Q 2024-11-14 0001493152-24-046088
us-gaap AvailableForSaleDebtSecuritiesGrossUnrealizedGain Debt Securities, Available-for-sale, Unrealized Gain USD 3,000 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-14 0001493152-24-046088
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 81,000 2024-09-30 2024 Q3 10-Q 2024-11-14 0001493152-24-046088
us-gaap BankOverdrafts Bank Overdrafts USD 118,000 2024-09-30 2024 Q3 10-Q 2024-11-14 0001493152-24-046088
us-gaap BridgeLoan Bridge Loan USD 200,000 2022-05-01 S-1 2026-09-08 0001493152-26-041808
us-gaap BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability USD 7.00M 2025-12-08 S-1 2026-09-08 0001493152-26-041808
us-gaap Cash Cash USD 3.80M 2025-09-30 2025 Q3 10-Q 2025-11-13 0001493152-25-022373
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 1.72M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 1.70M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 1.72M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 214,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 214,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 1.50M 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 250,000 2022-06-30 2022 Q2 10-Q 2022-08-11 0001493152-22-022098
us-gaap CashUninsuredAmount Cash, Uninsured Amount GBP 96,000 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 30,000 2023-10-22 S-1 2026-09-08 0001493152-26-041808
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 257 2026-08-28 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 250.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 73,866 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 73,866 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap CommonStockValue Common Stock, Value, Issued USD 19,000 2025-03-31 2025 Q1 10-Q/A 2025-08-14 0001641172-25-024123
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -13.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap ConversionOfStockSharesConverted1 Conversion of Stock, Shares Converted shares 1,000 2022-11-04 2023 FY 10-K 2024-04-16 0001493152-24-014889
us-gaap ConvertibleDebt Convertible Debt GBP 950,000 2022-10-06 2023 FY 10-K 2024-04-16 0001493152-24-014889
us-gaap ConvertibleDebtFairValueDisclosures Convertible Debt, Fair Value Disclosures USD 300,000 2022-12-31 2023 FY 10-K 2024-04-16 0001493152-24-014889
us-gaap ConvertibleLongTermNotesPayable Convertible Notes Payable, Noncurrent USD 1.83M 2022-12-31 2023 FY 10-K 2024-04-16 0001493152-24-014889
us-gaap ConvertibleNotesPayable Convertible Notes Payable USD 800,000 2024-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 800,000 2024-12-31 2025 Q2 10-Q 2025-08-14 0001641172-25-024140
us-gaap CryptoAssetCost CryptoAssetCost USD 997.61M 2025-09-30 2025 Q3 10-Q 2025-11-13 0001493152-25-022373
us-gaap CryptoAssetDisposition CryptoAssetDisposition USD 1.59M 2025-01-01 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap CryptoAssetFairValue CryptoAssetFairValue USD 989.93M 2025-09-30 2025 Q3 10-Q 2025-11-13 0001493152-25-022373
us-gaap CryptoAssetPeriodIncreaseDecrease CryptoAssetPeriodIncreaseDecrease USD -7.67M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-13 0001493152-25-022373
us-gaap CryptoAssetPurchase CryptoAssetPurchase USD 2.00M 2025-01-01 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap CryptoAssetRealizedAndUnrealizedGainLossOperatingAndNonoperating CryptoAssetRealizedAndUnrealizedGainLossOperatingAndNonoperating USD -403,000 2025-01-01 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD -374,862 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-28 0001493152-23-009306
us-gaap DebtConversionConvertedInstrumentRate Debt Conversion, Converted Instrument, Rate pure 0.2 2021-05-27 2024 Q1 10-Q/A 2024-11-14 0001493152-24-046074
us-gaap DebtConversionConvertedInstrumentSharesIssued1 Debt Conversion, Converted Instrument, Shares Issued shares 373,570 2023-09-22 2023 FY 10-K 2024-04-16 0001493152-24-014889
us-gaap DebtConversionOriginalDebtAmount1 Debt Conversion, Original Debt, Amount USD 1.50M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-28 0001493152-23-009306
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 200,000 2024-10-09 2024 FY 10-K 2025-03-28 0001641172-25-001246
us-gaap DebtInstrumentConvertibleConversionPrice1 Debt Instrument, Convertible, Conversion Price USD/shares 10 2023-06-30 2023 Q2 10-Q 2023-08-14 0001493152-23-028647
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 378,000 2026-07-31 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap DebtInstrumentFairValue Debt Instrument, Fair Value Disclosure USD 200,000 2026-03-31 2026 Q1 10-Q 2026-07-15 0001493152-26-033380
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.05 2021-05-27 2024 Q1 10-Q/A 2024-11-14 0001493152-24-046074
us-gaap DebtInstrumentPeriodicPaymentPrincipal Debt Instrument, Periodic Payment, Principal GBP 85,000 2024-10-09 2025 Q1 10-Q/A 2025-08-14 0001641172-25-024123
us-gaap DebtInstrumentRedemptionPricePercentage Debt Instrument, Redemption Price, Percentage pure 1 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-14 0001493152-23-028647
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 1.50M 2024-08-06 2024 FY 10-K 2025-03-28 0001641172-25-001246
us-gaap DebtSecuritiesTradingGainLoss Debt Securities, Trading, Gain (Loss) USD 400,000 2023-01-01 2023-09-30 2024 Q3 10-Q 2024-11-14 0001493152-24-046088
us-gaap DeferredCompensationLiabilityClassifiedNoncurrent Deferred Compensation Liability, Classified, Noncurrent USD 5.74M 2023-12-31 2024 FY 10-K 2025-03-28 0001641172-25-001246
us-gaap DeferredCompensationLiabilityCurrent Deferred Compensation Liability, Current USD 5.74M 2024-09-30 2024 Q3 10-Q 2024-11-14 0001493152-24-046088
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 108,962 2021-12-31 2022 FY 10-K 2023-03-28 0001493152-23-009306
us-gaap DeferredCostsCurrentAndNoncurrent Deferred Costs USD 108,962 2021-12-31 2021 FY 10-K 2022-03-29 0001493152-22-008049
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD -2.53M 2025-01-01 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD -1.55M 2025-01-01 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD -3.00M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-28 0001641172-25-001246
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 1.80M 2025-09-30 2025 Q3 10-Q 2025-11-13 0001493152-25-022373
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 4.08M 2022-12-31 2023 FY 10-K 2024-04-16 0001493152-24-014889
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 4.08M 2022-12-31 2023 FY 10-K 2024-04-16 0001493152-24-014889
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD -483,000 2025-01-01 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 4.46M 2024-12-31 2024 FY 10-K 2025-03-28 0001641172-25-001246
us-gaap DeferredTaxAssetsHedgingTransactions Deferred Tax Assets, Hedging Transactions USD 397,000 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 1.68M 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 6.52M 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 27,000 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 9.02M 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap DeferredTaxLiabilitiesDeferredExpense Deferred Tax Liabilities, Deferred Expense USD 211,627 2022-12-31 2022 FY 10-K 2023-03-28 0001493152-23-009306
us-gaap DemandDepositAccounts Demand Deposit Accounts USD 10.00M 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap DepositAssets Deposit Assets USD 114,000 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap Deposits Deposits USD 1.15M 2022-09-30 2022 Q3 10-Q 2022-11-07 0001493152-22-030830
us-gaap Depreciation Depreciation USD 10,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0001641172-25-024140
us-gaap DerivativeLiabilities Derivative Liability USD 24,000 2024-09-30 2024 Q3 10-Q 2024-11-14 0001493152-24-046088
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 100,000 2024-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 187,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap DividendsCash Dividends, Cash USD 0 2025-01-01 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap DueToRelatedPartiesCurrentAndNoncurrent Due to Related Parties USD 3,875 2022-03-31 2022 Q1 10-Q 2022-05-18 0001493152-22-014244
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -2,310.55 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares 0 2021-10-19 2021-12-31 2021 FY 10-K 2022-03-29 0001493152-22-008049
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -2,310.55 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.065 2025-01-01 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2024-01-01 2024-06-30 2024 Q2 10-Q/A 2024-11-14 0001493152-24-046080
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure -0.055 2025-01-01 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.003 2025-01-01 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD -75,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 40,000 2023-12-31 2023 FY 10-K 2024-04-16 0001493152-24-014889
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 600,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap EmployeeStockOwnershipPlanESOPDeferredSharesFairValue Employee Stock Ownership Plan (ESOP), Deferred Shares, Fair Value USD 78,000 2025-03-30 2025 Q1 10-Q/A 2025-08-14 0001641172-25-024123
us-gaap EquityMethodInvestmentOwnershipPercentage Equity Method Investment, Ownership Percentage pure 0.15 2022-03-31 2022 Q1 10-Q 2022-05-18 0001493152-22-014244
us-gaap EquityMethodInvestments Equity Method Investments USD 153.48M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap ExpenseRelatedToDistributionOrServicingAndUnderwritingFees Expense Related to Distribution or Servicing and Underwriting Fees USD 2.65M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-14 0001493152-23-028647
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD -465,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap FairValueOptionChangesInFairValueGainLoss1 Fair Value, Option, Changes in Fair Value, Gain (Loss) USD 100,000 2025-01-01 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap FederalDepositInsuranceCorporationPremiumExpense Federal Deposit Insurance Corporation Premium Expense USD 250,000 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-14 0001493152-23-028647
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 400,000 2025-03-31 2025 Q1 10-Q/A 2025-08-14 0001641172-25-024123
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD 10,000 2023-01-01 2023-06-30 2024 Q2 10-Q/A 2024-11-14 0001493152-24-046080
us-gaap ForeignCurrencyTransactionGainLossUnrealized Foreign Currency Transaction Gain (Loss), Unrealized USD 1,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap ForeignCurrencyTransactionGainLossUnrealizedAfterTax ForeignCurrencyTransactionGainLossUnrealizedAfterTax USD 28,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap ForeignCurrencyTransactionLossBeforeTax Foreign Currency Transaction Loss, before Tax USD 11,000 2024-01-01 2024-06-30 2025 Q2 10-Q 2025-08-14 0001641172-25-024140
us-gaap GainLossOnInvestments Gain (Loss) on Investments USD -452,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap GainOrLossOnSaleOfStockInSubsidiary Gain (Loss) on Disposition of Stock in Subsidiary USD 34,000 2022-01-01 2022-09-30 2023 Q3 10-Q/A 2023-11-21 0001493152-23-042184
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD -2.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 8.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -22.07M 2025-01-01 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -39.22M 2025-01-01 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD -17.16M 2025-01-01 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap IncomeTaxExaminationPenaltiesAndInterestAccrued Income Tax Examination, Penalties and Interest Accrued USD 0 2022-12-31 2022 FY 10-K 2023-03-28 0001493152-23-009306
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 249,292 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-14 0001493152-23-028647
us-gaap IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability USD 3.00M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-28 0001641172-25-001246
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 2.53M 2025-01-01 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap IncomeTaxReconciliationDeductionsOther Effective Income Tax Rate Reconciliation, Deduction, Other, Amount USD 129,000 2025-01-01 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 2.15M 2025-01-01 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -8.24M 2025-01-01 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 1.50M 2025-01-01 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Meals and Entertainment, Amount USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-28 0001641172-25-001246
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD -59,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-28 0001641172-25-001246
us-gaap IncomeTaxReconciliationNondeductibleExpenseRestructuringCharges Effective Income Tax Rate Reconciliation, Nondeductible Expense, Restructuring Charges, Amount USD 84,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-28 0001641172-25-001246
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 710,000 2024-01-01 2024-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 2.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 811,000 2024-01-01 2024-06-30 2024 Q2 10-Q/A 2024-11-14 0001493152-24-046080
us-gaap IncreaseDecreaseInAccruedIncomeTaxesPayable Increase (Decrease) in Income Taxes Payable USD -263,138 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-14 0001493152-23-028647
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -18,585 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-14 0001493152-23-028647
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD 108,962 2022-01-01 2022-06-30 2023 Q2 10-Q 2023-08-14 0001493152-23-028647
us-gaap IncreaseDecreaseInDueToRelatedParties Increase (Decrease) in Due to Related Parties USD 3,875 2022-01-01 2022-03-31 2023 Q1 10-Q 2023-05-15 0001493152-23-017281
us-gaap IncreaseDecreaseInIntangibleAssetsCurrent Increase (Decrease) in Intangible Assets, Current USD -5,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-28 0001641172-25-001246
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -105,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities Increase (Decrease) in Other Accounts Payable and Accrued Liabilities USD -136,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0001641172-25-024140
us-gaap IncreaseDecreaseInOtherCurrentLiabilities Increase (Decrease) in Other Current Liabilities USD 613,000 2023-01-01 2023-06-30 2024 Q2 10-Q/A 2024-11-14 0001493152-24-046080
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 1.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD -224,133 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-14 0001493152-23-028647
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 5,000 2022-12-31 2023 FY 10-K 2024-04-16 0001493152-24-014889
us-gaap InterestExpense Interest Expense USD 200,000 2025-01-01 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap InterestExpenseDebt Interest Expense, Debt USD 40,000 2024-01-01 2024-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 547,000 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-14 0001493152-24-046088
us-gaap InterestExpenseOther Interest Expense, Other USD 281,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-13 0001493152-25-022373
us-gaap InterestIncomeExpenseAfterProvisionForLoanLoss Interest Income (Expense), after Provision for Loan Loss USD 33,000 2023-07-01 2023-09-30 2023 Q3 10-Q/A 2023-11-21 0001493152-23-042184
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD -197,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap InterestIncomeOther Interest Income, Other USD 19,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 11,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap InterestPayableCurrent Interest Payable, Current USD 383,000 2024-12-31 2025 Q3 10-Q 2025-11-13 0001493152-25-022373
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 11,000 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-14 0001493152-24-046088
us-gaap InvestmentIncomeNet Investment Income, Net USD 19,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 963,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap LeaseCost Lease, Cost USD 285,000 2025-01-01 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 122,000 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 122,000 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 113,000 2024-12-31 2024 FY 10-K 2025-03-28 0001641172-25-001246
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 7,000 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap Liabilities Liabilities USD 22.33M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 158.73M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap LiabilitiesAssumed1 Liabilities Assumed USD 350,000 2024-01-01 2024-03-31 2025 Q1 10-Q/A 2025-08-14 0001641172-25-024123
us-gaap LiabilitiesCurrent Liabilities, Current USD 22.15M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap LineOfCreditFacilityCurrentBorrowingCapacity Line of Credit Facility, Current Borrowing Capacity USD 500,000 2024-03-04 2024 Q1 10-Q/A 2024-11-14 0001493152-24-046074
us-gaap LineOfCreditFacilityInterestRateDuringPeriod Line of Credit Facility, Interest Rate During Period pure 0.095 2024-03-04 2024 Q1 10-Q/A 2024-11-14 0001493152-24-046074
us-gaap LineOfCreditFacilityMaximumBorrowingCapacity Line of Credit Facility, Maximum Borrowing Capacity USD 1.00M 2024-03-04 2024 Q1 10-Q/A 2024-11-14 0001493152-24-046074
us-gaap LitigationSettlementExpense Litigation Settlement, Expense USD 2.00M 2023-09-07 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap LoansPayable Loans Payable USD 200,000 2024-12-31 2025 Q1 10-Q/A 2025-08-14 0001641172-25-024123
us-gaap LoansPayableCurrent Loans Payable, Current USD 1.49M 2024-09-30 2024 Q3 10-Q 2024-11-14 0001493152-24-046088
us-gaap LossContingencyAccrualProvision Loss Contingency Accrual, Provision USD 400,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-28 0001641172-25-001246
us-gaap LossContingencyLossInPeriod Loss Contingency, Loss in Period USD 400,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-13 0001493152-25-022373
us-gaap MarketableSecurities Marketable Securities USD 81,000 2024-09-30 2024 Q3 10-Q 2024-11-14 0001493152-24-046088
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 5.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -150,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -5.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD 5.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -13.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -39.22M 2025-01-01 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -39.22M 2025-01-01 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap NoninterestIncomeOther Noninterest Income, Other USD 4,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -2.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap NotesPayableCurrent Notes Payable, Current USD 183,000 2024-03-31 2024 Q1 10-Q/A 2024-11-14 0001493152-24-046074
us-gaap NotesReduction Notes Reduction USD 3.69M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-28 0001641172-25-001246
us-gaap NumberOfReportableSegments Number of Reportable Segments Integer 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap OperatingCostsAndExpenses Operating Costs and Expenses USD 4,381 2021-10-19 2021-12-31 2021 FY 10-K 2022-03-29 0001493152-22-008049
us-gaap OperatingExpenses Operating Expenses USD 10.55M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -10.55M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap OperatingLeaseCost Operating Lease, Cost USD 142,000 2025-01-01 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 115,000 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 9,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 107,000 2024-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap OperatingLeasePayments Operating Lease, Payments USD 125,000 2025-01-01 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 29,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.112 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 689,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap OtherAssetsCurrent Other Assets, Current USD 51,000 2024-06-30 2024 Q2 10-Q/A 2024-11-14 0001493152-24-046080
us-gaap OtherCommitment Other Commitment USD 5.00M 2024-03-04 2024 Q1 10-Q/A 2024-11-14 0001493152-24-046074
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent USD 181,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD 181,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap OtherExpenses Other Expenses USD 6,000 2025-01-01 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap OtherGeneralAndAdministrativeExpense Other General and Administrative Expense USD 2.75M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-13 0001493152-25-022373
us-gaap OtherIncome Other Income USD 7,000 2024-01-01 2024-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 131,000 2023-09-30 2023 Q3 10-Q/A 2023-11-21 0001493152-23-042184
us-gaap OtherLongTermInvestments Other Long-term Investments USD 100,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 2.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 1.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 4.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap OtherNotesPayable Other Notes Payable USD 1.20M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 579,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 489,000 2024-12-31 2025 Q3 10-Q 2025-11-13 0001493152-25-022373
us-gaap OtherResearchAndDevelopmentExpense Other Research and Development Expense USD 3.39M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-13 0001493152-25-022373
us-gaap PaymentForAcquisitionCryptoAsset PaymentForAcquisitionCryptoAsset USD 1.00M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap PaymentsForRent Payments for Rent USD 10,000 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-14 0001493152-23-028647
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 106,000 2025-01-01 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 45,450 2021-10-19 2021-12-31 2022 FY 10-K 2023-03-28 0001493152-23-009306
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 3.11M 2022-01-01 2022-06-30 2023 Q2 10-Q 2023-08-14 0001493152-23-028647
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 134.90M 2022-01-01 2022-06-30 2023 Q2 10-Q 2023-08-14 0001493152-23-028647
us-gaap PaymentsToAcquireProductiveAssets Payments to Acquire Productive Assets USD 398,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-13 0001493152-25-022373
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 405,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0001641172-25-024140
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 5,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap PaymentsToFundLongtermLoansToRelatedParties Payments to Fund Long-term Loans to Related Parties USD 357,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-28 0001641172-25-001246
us-gaap PaymentsToInvestInDecommissioningFund Payments to Acquire Investments to be Held in Decommissioning Trust Fund USD 389,942 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-14 0001493152-23-028647
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 1.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2024-09-30 2024 Q3 10-Q 2024-11-14 0001493152-24-046088
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2024-09-30 2024 Q3 10-Q 2024-11-14 0001493152-24-046088
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 1.83M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap PrepaidExpenseAndOtherAssetsNoncurrent Prepaid Expense and Other Assets, Noncurrent USD 623,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 197,000 2024-09-30 2024 Q3 10-Q 2024-11-14 0001493152-24-046088
us-gaap PrepaidExpenseCurrentAndNoncurrent Prepaid Expense USD 400,000 2024-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap PrepaidExpenseNoncurrent Prepaid Expense, Noncurrent USD 45,302 2022-06-30 2022 Q2 10-Q 2022-08-11 0001493152-22-022098
us-gaap PrepaidInsurance Prepaid Insurance USD 970,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap ProceedsFromBankDebt Proceeds from Bank Debt USD 118,000 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-14 0001493152-24-046088
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 500,000 2026-03-03 2026 Q1 10-Q 2026-07-15 0001493152-26-033380
us-gaap ProceedsFromDecommissioningFund Proceeds from Decommissioning Trust Fund Assets USD 114.07M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-14 0001493152-23-028647
us-gaap ProceedsFromDisposalCryptoAsset ProceedsFromDisposalCryptoAsset USD 1.59M 2025-01-01 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 132.25M 2022-01-01 2022-06-30 2023 Q2 10-Q 2023-08-14 0001493152-23-028647
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 5.57M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 7.54M 2022-01-01 2022-06-30 2023 Q2 10-Q 2023-08-14 0001493152-23-028647
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised USD 498,000 2023-01-01 2023-09-30 2023 Q3 10-Q/A 2023-11-21 0001493152-23-042184
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 113,000 2024-01-01 2024-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 1.34M 2022-01-01 2022-12-31 2023 FY 10-K 2024-04-16 0001493152-24-014889
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 3.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 600,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-28 0001641172-25-001246
us-gaap ProceedsFromRepaymentsOfBankOverdrafts Proceeds from (Repayments of) Bank Overdrafts USD 118,000 2024-01-01 2024-09-30 2025 Q3 10-Q 2025-11-13 0001493152-25-022373
us-gaap ProceedsFromSaleOfShortTermInvestments Proceeds from Sale of Short-term Investments USD 498,000 2024-01-01 2024-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 200,000 2024-12-11 2025 Q1 10-Q/A 2025-08-14 0001641172-25-024123
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 102,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap RedeemableNoncontrollingInterestEquityRedemptionValue Redeemable Noncontrolling Interest, Equity, Redemption Value USD 5.00M 2022-09-30 2022 Q3 10-Q 2022-11-07 0001493152-22-030830
us-gaap RepaymentsOfConvertibleDebt Repayments of Convertible Debt USD 659,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 3.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 177,057 2022-01-01 2022-06-30 2023 Q2 10-Q 2023-08-14 0001493152-23-028647
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 1.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -81.61M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 352,000 2024-01-01 2024-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap RoyaltyExpense Royalty Expense GBP 19.20M 2020-06-03 2024 Q1 10-Q/A 2024-11-14 0001493152-24-046074
us-gaap SalariesAndWages Salary and Wage, NonOfficer, Excluding Cost of Good and Service Sold GBP 240.00M 2025-04-12 2025 Q1 10-Q/A 2025-08-14 0001641172-25-024123
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 23.90M 2024-10-23 S-1 2026-09-08 0001493152-26-041808
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 54.00M 2023-10-22 S-1 2026-09-08 0001493152-26-041808
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 597,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 745,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-28 0001641172-25-001246
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value USD/shares 551 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-28 0001641172-25-001246
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 52,000 2025-01-01 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 3,480 2025-01-01 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 745,000 2023-12-31 2024 FY 10-K 2025-03-28 0001641172-25-001246
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 551 2023-12-31 2024 FY 10-K 2025-03-28 0001641172-25-001246
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 52,000 2025-01-01 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 3,480 2025-01-01 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price USD/shares 9.36M 2024-04-20 S-1 2026-09-08 0001493152-26-041808
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-01-01 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 1.585 2025-01-01 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.048 2024-04-20 S-1 2026-09-08 0001493152-26-041808
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 0 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 15,449 2025-03-31 2025 Q3 10-Q 2025-11-13 0001493152-25-022373
us-gaap SharePrice Share Price USD/shares 3,480 2025-08-12 S-1 2026-09-08 0001493152-26-041808
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 0.035 2023-01-26 2023 Q2 10-Q 2023-08-14 0001493152-23-028647
us-gaap SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Fair Value of Shares USD 1.50M 2025-09-30 2025 Q3 10-Q 2025-11-13 0001493152-25-022373
us-gaap SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Number of Shares shares 2.19M 2023-06-30 2023 Q2 10-Q 2023-08-14 0001493152-23-028647
us-gaap ShortTermInvestments Short-term Investments USD 600,000 2025-03-31 2025 Q1 10-Q/A 2025-08-14 0001641172-25-024123
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 128,000 2025-01-01 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap SponsorFees Sponsor Fees USD 1.50M 2022-02-09 2022-02-10 2022 FY 10-K 2023-03-28 0001493152-23-009306
us-gaap StockGrantedDuringPeriodValueSharebasedCompensationGross Shares Granted, Value, Share-based Payment Arrangement, before Forfeiture USD 597,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 136.39M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap StockIssued1 Stock Issued USD 544,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-28 0001641172-25-001246
us-gaap StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities Stock Issued During Period, Shares, Conversion of Convertible Securities shares 373.57B 2023-09-22 2024 Q1 10-Q/A 2024-11-14 0001493152-24-046074
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 3 2024-10-11 2025 FY 10-K 2026-04-15 0001493152-26-016858
us-gaap StockIssuedDuringPeriodSharesReverseStockSplits Stock Issued During Period, Shares, Reverse Stock Splits shares 100 2024-01-24 2024 FY 10-K 2025-03-28 0001641172-25-001246
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 15.09M 2023-01-01 2023-09-30 2024 Q3 10-Q 2024-11-14 0001493152-24-046088
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 3.69M 2023-01-01 2023-09-30 2024 Q3 10-Q 2024-11-14 0001493152-24-046088
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 963,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 1.57M 2024-01-01 2024-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 1.63M 2024-01-01 2024-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 4.08M 2025-01-01 2025-03-31 2025 Q1 10-Q/A 2025-08-14 0001641172-25-024123
us-gaap StockRedeemedOrCalledDuringPeriodShares Stock Redeemed or Called During Period, Shares shares 11.04M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-14 0001493152-23-028647
us-gaap StockRedeemedOrCalledDuringPeriodValue Stock Redeemed or Called During Period, Value USD 114.07M 2023-01-01 2023-03-31 2023 Q2 10-Q 2023-08-14 0001493152-23-028647
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 106,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap TemporaryEquityAccretionToRedemptionValueAdjustment Temporary Equity, Accretion to Redemption Value, Adjustment USD 247,094 2023-04-01 2023-06-30 2023 Q2 10-Q 2023-08-14 0001493152-23-028647
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 23.11M 2023-06-30 2023 Q2 10-Q 2023-08-14 0001493152-23-028647
us-gaap TemporaryEquityRedemptionPricePerShare Temporary Equity, Redemption Price Per Share USD/shares 10.56 2023-06-30 2023 Q2 10-Q 2023-08-14 0001493152-23-028647
us-gaap TreasuryStockCommonShares Treasury Stock, Common, Shares shares 11,713 2025-06-30 2025 Q2 10-Q 2025-08-14 0001641172-25-024140
us-gaap TreasuryStockCommonValue Treasury Stock, Common, Value USD 106,000 2025-06-30 2025 Q2 10-Q 2025-08-14 0001641172-25-024140
us-gaap UnrealizedGainLossOnDerivatives Unrealized Gain (Loss) on Derivatives USD 131,000 2023-01-01 2023-09-30 2023 Q3 10-Q/A 2023-11-21 0001493152-23-042184
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2022-12-31 2022 FY 10-K 2023-03-28 0001493152-23-009306
us-gaap VariableLeaseCost Variable Lease, Cost USD 15,000 2025-01-01 2025-12-31 S-1 2026-09-08 0001493152-26-041808
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 13.98M 2022-06-30 2022 Q2 10-Q 2022-08-11 0001493152-22-022098
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 78.31M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-14 0001493152-24-046088
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 5,751 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 2.88M 2021-10-19 2021-12-31 2021 FY 10-K 2022-03-29 0001493152-22-008049
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 5,751 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052618

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →